Semax is a 7-amino-acid peptide studied in cognitive and neuropeptide research. Patients can request a telehealth evaluation through the TelosRX Telehealth Portal to discuss compounded access.
What Is Semax?
Semax is a synthetic heptapeptide derived from a fragment of ACTH. It is studied in preclinical research for cognitive and neuropeptide pathways.
Semax is not an FDA-approved drug in the United States. It is available through compounding pharmacies under valid prescription.
Common Discussion Points
Patients often raise Semax during evaluations for:
- Cognitive performance research interest
- Focus and attention discussions
- Stress response research
- Neuropeptide pathway exploration
A licensed provider determines clinical appropriateness individually.
Pre-PCAC July 2026 Regulatory Context
Semax is under PCAC review ahead of the July 2026 meeting. Patients interested in compounded access should consult a licensed provider while it remains available.
How TelosRX Handles Semax
TelosRX is an online-first telehealth service. Patient evaluation is asynchronous, and compounded medications are prepared through our licensed pharmacy partner.
- Step 1: Complete an asynchronous telehealth intake at TelosRX.
- Step 2: Licensed provider review.
- Step 3: Prescription issued if clinically appropriate.
- Step 4: Compounded Semax ships discreetly to your door.
Important Compliance Information
Semax is not FDA-approved in the United States. Compounded preparations are prepared under federal compounding regulations.
Prescriptions require evaluation by a licensed healthcare provider. Approval is not guaranteed. Individual results vary.
TelosRX operates under LegitScript-certified telehealth standards.
Start your private evaluation at TelosRX.